Screener
Fulgent Genetics, Inc. FLGT Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Acquisition of businesses, net of cash | (55,567) | — |
| Net cash provided by investing activities | 10,939 | 27,729 |
| Cash flow from financing activities: | ||
| Repurchase of common stock | (40,078) | (8,679) |
| Common stock withholding for employee tax obligations | (4,200) | (1,887) |
| Repayment of notes payable | (476) | (470) |
| Principal paid for finance lease | (88) | (136) |
| Proceeds from exercise of stock options | 9 | — |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s share buybacks?
- Fulgent Genetics, Inc. (FLGT) reported share buybacks of $40.08M in Q1 2026.
- How has Fulgent Genetics, Inc.'s share buybacks changed year-over-year?
- Fulgent Genetics, Inc.'s share buybacks increased by 361.8% year-over-year, from $8.68M to $40.08M.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about Fulgent Genetics, Inc.'s share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude